Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Dec-20 1:32 PM View:  | Surface Oncology, Inc. (SURF) | 17-Dec-20 | Private Sale | 1,700,000 | $18.10 | $30,770,000.00 | (37%) 4.65M to 2.95M | |
| 23-Apr-18 4:18 PM View: | Surface Oncology, Inc. (SURF) | 23-Apr-18 | Conversion | 3,181,820 | -- | -- | 233% 1.36M to 4.55M | |
| 23-Apr-18 4:18 PM View: | Surface Oncology, Inc. (SURF) | 23-Apr-18 | Purchase | 100,000 | $15.00 | $1,500,000.00 | 2% 4.55M to 4.65M | |
| 03-Apr-18 5:11 PM View: | Cogent Biosciences, Inc. (COGT) | 03-Apr-18 | Conversion | 3,267,480 | -- | -- | 100% 0 to 3.27M | |
| 03-Apr-18 5:11 PM View: | Cogent Biosciences, Inc. (COGT) | 03-Apr-18 | Purchase | 94,052 | $12.00 | $1,128,620.00 | 3% 3.27M to 3.36M | |
| 11-Jul-17 5:37 PM View: | Intellia Therapeutics, Inc. (NTLA) | 11-Jul-17 | Market Sale | 80,000 | $16.07 | $1,285,560.00 | (2%) 3.66M to 3.58M | (286%) |
| 11-Jul-17 5:37 PM View: | Intellia Therapeutics, Inc. (NTLA) | 10-Jul-17 | Market Sale | 40,000 | $16.17 | $646,888.00 | (1%) 3.7M to 3.66M | (284%) |
| 11-Jul-17 5:37 PM View: | Intellia Therapeutics, Inc. (NTLA) | 07-Jul-17 | Market Sale | 30,000 | $16.77 | $502,992.00 | (< 1%) 3.73M to 3.7M | (270%) |
| 07-Mar-17 8:35 AM View: | Intellia Therapeutics, Inc. (NTLA) | 03-Mar-17 | Disposition (other) | 700,000 | -- | -- | (16%) 4.43M to 3.73M | |
| 11-May-16 6:59 PM View: | Intellia Therapeutics, Inc. (NTLA) | 11-May-16 | Conversion | 4,429,790 | -- | -- | 100% 0 to 4.43M |